Coherus BioSciences, Inc. announced that it has received $38.7 million in a round of funding on May 9, 2024. The company has issued term loan in the transaction. The loan will mature in May 2029.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.01 USD | -4.74% | -7.37% | -39.64% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.64% | 231M | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.41% | 21.58B | |
-11.04% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Coherus BioSciences, Inc. announced that it has received $38.7 million in funding